Personensuche
Personensuche
Es wurde 1 Person gefunden.
Aktuelle Veranstaltungen
-
SoSe 2025
- Tagespraktikum Kardiologie
- Kardiologisch-chirurgische Konferenz (*)
- Wiss. Arbeiten der Abteilung Kardiologie (*)
- Klinische Visite Kardiologie (*)
- Akute und chronische Herzinsuffizienz
- Blockpraktikum Innere Medizin (PV)
- Auskultation und Echokardiografie am Krankenbett (*)
- Kardiovasculäres Kolloquium (*)
Vergangene Veranstaltungen (max. 10)
-
WiSe 2024
- Tagespraktikum Kardiologie
- Wiss. Arbeiten der Abteilung Kardiologie (*)
- Akute und chronische Herzinsuffizienz
- Kardiologisch-chirurgische Konferenz (*)
- Auskultation und Echokardiografie am Krankenbett (*)
- Klinische Visite Kardiologie (*)
- Kardiovasculäres Kolloquium (*)
- Blockpraktikum Innere Medizin (PV)
-
SoSe 2024
Die folgenden Publikationen sind in der Online-Universitätsbibliographie der Universität Duisburg-Essen verzeichnet. Weitere Informationen finden Sie gegebenenfalls auch auf den persönlichen Webseiten der Person.
-
Cardiac magnetic resonance imaging in patients with suspected myocarditis from immune checkpoint inhibitor therapy : A real-world observational studyIn: International Journal of Cardiology (IJC) Heart & Vasculature , Jg. 56 2025, 101581DOI (Open Access)
-
Delays in diagnosis and treatment of ATTR cardiac amyloidosis : A real-world data analysisIn: ESC Heart Failure 2025 , in pressDOI (Open Access)
-
Epicardial adipose tissue in patients with and without COVID-19 infectionIn: American Heart Journal Plus , Jg. 54 2025, 100548DOI (Open Access)
-
Gain or amplification of 1q21 in systemic light chain amyloidosis is associated with advanced Mayo stage, plasma cell disease and worse overall survivalIn: Annals of Hematology , Jg. 104 2025, Nr. 3, S. 1777 – 1788DOI (Open Access)
-
Hemoglobin is associated with cardiotoxicity in melanoma patients without anemia receiving immune checkpoint inhibitor therapyIn: International Journal of Cardiology (IJC) Heart & Vasculature , Jg. 59 2025, 101693DOI (Open Access)
-
Novel three-dimensional ECG algorithm for reliable screening for cardiac amyloidosisIn: ESC Heart Failure 2025 , in pressDOI (Open Access)
-
Preclinical models of cardiotoxicity from immune checkpoint inhibitor therapyIn: Basic Research in Cardiology , Jg. 120 2025, Nr. 1, S. 171 – 185DOI (Open Access)
-
Prevention of cancer-therapy related cardiac dysfunctionIn: Current Heart Failure Reports , Jg. 22 2025, Nr. 1, 9DOI (Open Access)
-
Propensity Matched Analysis of 14 French Suture‐ Versus Plug‐Based Vascular Closure During Transfemoral Transcatheter Aortic Valve Replacement (TAVR)In: Catheterization and Cardiovascular Interventions 2025 , in pressDOI (Open Access)
-
Real-world characteristics and treatment of cardiac transthyretin amyloidosis : A multicentre, observational studyIn: ESC Heart Failure , Jg. 12 2025, Nr. 2, S. 1203 – 1216DOI (Open Access)
-
(Non)-Exertional Variables of Cardiopulmonary Exercise Testing in Heart Failure with and Without Cardiac AmyloidosisIn: Current Heart Failure Reports , Jg. 21 2024, Nr. 3, S. 224 – 237DOI (Open Access)
-
Cellular Alterations in Immune Checkpoint Inhibitor Therapy-Related Cardiac DysfunctionIn: Current Heart Failure Reports , Jg. 21 2024, Nr. 3, S. 214 – 223DOI (Open Access)
-
Current Therapies and Future Horizons in Cardiac Amyloidosis TreatmentIn: Current Heart Failure Reports , Jg. 21 2024, Nr. 4, S. 305 – 321DOI (Open Access)
-
Detectable troponin below the 99th percentile predicts survival in patients undergoing coronary angiographyIn: International Journal of Cardiology (IJC) Heart & Vasculature , Jg. 52 2024, 101419DOI, Online Volltext (Open Access)
-
Dual transcatheter edge-to-edge repair in a patient with cardiac amyloidosis and severe secondary mitral and tricuspid regurgitation : A case reportIn: European Heart Journal - Case Reports (EHJ-Case Reports) , Jg. 8 2024, Nr. 12, ytae601DOI (Open Access)
-
FAPI PET Imaging Supports Clinical Decision Making in Academic Cardiology Practice : A Pictorial Imaging VignetteIn: JACC Cardiovascular Imaging , Jg. 17 2024, Nr. 7, S. 811 – 823DOI (Open Access)
-
Herz und Krebs : KardioonkologieIn: Herz: Cardiovascular Diseases , Jg. 49 2024, Nr. 2, S. 111 – 117
-
High neutrophil-to-lymphocyte ratio is associated with cancer therapy-related cardiovascular toxicity in high-risk cancer patients under immune checkpoint inhibitor therapyIn: Clinical Research in Cardiology , Jg. 113 2024, Nr. 2, S. 301 – 312DOI (Open Access)
-
Onkologische Kardiologie : Das neue Fachgebiet der KardiologieIn: Arzneimitteltherapie (AMT) , Jg. 42 2024, Nr. 5, S. 176 – 185
-
Onkologische KardiologieIn: Medizinische Monatsschrift für Pharmazeuten, MMP , Jg. 47 2024, Nr. 5, S. 170 – 179
-
Stroke and myocardial infarction induce neutrophil extracellular trap release disrupting lymphoid organ structure and immunoglobulin secretionIn: Nature Cardiovascular Research , Jg. 3 2024, Nr. 5, S. 525 – 540DOI (Open Access)
-
Update Kardioonkologie : Immuncheckpoint-Inhibitor-TherapieIn: Herz: Cardiovascular Diseases , Jg. 49 2024, Nr. 1, S. 81 – 90
-
Anthracycline Therapy Modifies Immune Checkpoint Signaling in the HeartIn: International Journal of Molecular Sciences (IJMS) , Jg. 24 2023, Nr. 7, 6052DOI, Online Volltext (Open Access)
-
ESC-Leitlinie 2022 onkologische Kardiologie : Kardiovaskuläre Nebenwirkungen durch Krebstherapie verstehen und behandelnIn: Herz: Cardiovascular Diseases , Jg. 48 2023, Nr. 1, S. 15 – 22
-
Frequency and prognosis of CVD and myocardial injury in patients presenting with suspected COVID-19 : The CoV-COR registryIn: International Journal of Cardiology (IJC) Heart & Vasculature , Jg. 45 2023, 101184DOI (Open Access)
-
Update Kardioonkologie : Anthrazyklin-ChemotherapieIn: Die Kardiologie , Jg. 17 2023, Nr. 6, S. 449 – 460
-
Cardiotoxicity from chimeric antigen receptor-T cell therapy for advanced malignanciesIn: European Heart Journal , Jg. 43 2022, Nr. 20, S. 1928 – 1940DOI (Open Access)
-
Kardiologische Langzeitfolgen nach Malignom-BehandlungIn: MMW - Fortschritte der Medizin , Jg. 164 2022, Nr. 2, S. 48 – 56
-
Medikamentös bedingte KardiomyopathienIn: Deutsche Medizinische Wochenschrift - DMW , Jg. 147 2022, Nr. 23, S. 1513 – 1522
-
PD1 Deficiency Modifies Cardiac Immunity during Baseline Conditions and in Reperfused Acute Myocardial InfarctionIn: International Journal of Molecular Sciences (IJMS) , Jg. 23 2022, Nr. 14, 7533DOI, Online Volltext (Open Access)
-
Right ventricular and atrial strain in patients with advanced melanoma undergoing immune checkpoint inhibitor therapyIn: ESC Heart Failure , Jg. 9 2022, Nr. 5, S. 3533 – 3542DOI, Online Volltext (Open Access)
-
Targeting early stages of cardiotoxicity from anti-PD1 immune checkpoint inhibitor therapyIn: European Heart Journal , Jg. 43 2022, Nr. 4, S. 316 – 329
-
Assessment of coronary artery disease during hospitalization for cancer treatmentIn: Clinical Research in Cardiology , Jg. 110 2021, Nr. 2, S. 200 – 210DOI (Open Access)
-
Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer—a meta-analysisIn: ESC Heart Failure , Jg. 7 2020, Nr. 2, S. 423 – 433DOI, Online Volltext (Open Access)
-
ECG Changes in Melanoma Patients Undergoing Cancer Therapy : Data from the ECoR RegistryIn: Journal of Clinical Medicine (JCM) , Jg. 9 2020, Nr. 7, 2060DOI, Online Volltext (Open Access)
-
Emerging role of immune checkpoint inhibitors and their relevance for the cardiovascular systemIn: Herz: Cardiovascular Diseases , Jg. 45 2020, S. 645 – 651
-
Evaluating biomarkers as predictors of cancer therapy cardiotoxicity : All you need is a meta-analysis? ReplyIn: European Journal of Heart Failure , Jg. 22 2020, Nr. 7, S. 1285 – 1286DOI (Open Access)
-
Onkokardiologie : Neue Herausforderungen, neue MöglichkeitenIn: Herz: Cardiovascular Diseases , Jg. 45 2020, S. 619 – 625DOI (Open Access)
-
Troponins and Natriuretic Peptides in Cardio-Oncology Patients—Data From the ECoR RegistryIn: Frontiers in Pharmacology , Jg. 11 2020, S. 740DOI (Open Access)
-
Troponins and brain natriuretic peptides for the prediction of cardiotoxicity in cancer patients : a meta-analysisIn: European Journal of Heart Failure , Jg. 22 2020, Nr. 2, S. 350 – 361DOI (Open Access)
-
Cardio-oncology : need for novel structuresIn: European Journal of Medical Research , Jg. 24 2019, Nr. 1, S. 1DOI (Open Access)
-
Cardiotoxicity from immune checkpoint inhibitorsIn: International Journal of Cardiology (IJC) Heart & Vasculature , Jg. 25 2019, S. 100420DOI (Open Access)
-
Cardiovascular Adverse Events Associated with BRAF and MEK Inhibitors : A Systematic Review and Meta-analysisIn: JAMA Network Open , Jg. 2 2019, Nr. 8, S. e198890DOI (Open Access)
-
Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseIn: Nature Communications , Jg. 10 2019, Nr. 1, S. 2312DOI (Open Access)
-
Fingolimod Improves the Outcome of Experimental Graves' Disease and Associated Orbitopathy by Modulating the Autoimmune Response to the Thyroid-Stimulating Hormone ReceptorIn: Thyroid , Jg. 29 2019, Nr. 9, S. 1286 – 1301
-
Publisher Correction: Contemporaneous 3D characterization of acute and chronic myocardial I/R injury and responseIn: Nature Communications , Jg. 10 2019, Nr. 1, S. 2768DOI (Open Access)
-
Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicityIn: Journal of Thoracic Disease , Jg. 10 2018, S. S4282 – S4295DOI (Open Access)
-
Real-time pressure-volume analysis of acute myocardial infarction in miceIn: JoVE 2018, Nr. 137, S. e57621DOI (Open Access)
-
GFI136N as a therapeutic and prognostic marker for myelodysplastic syndromeIn: Experimental Hematology , Jg. 44 2016, Nr. 7, S. 590 – 595.e1DOI (Open Access)
-
Gfi136N is a novel prognostic marker for the progression of myelodysplastic syndrome to Acute myeloid leukemiaIn: Onkologie , Jg. 36 2013, Nr. Suppl. 7, S. 188 – 188
-
The inflammatory and nutritional status in patients with dilated cardiomyopathy : Different impact for distinct phenogroups?In: International Journal of Cardiology (IJC) Heart & Vasculature , Jg. 56 2025, 101610DOI (Open Access)
-
Cardiac dysfunction from cancer and cancer therapy : new pathways for the prevention of late cardiotoxicityIn: Basic Research in Cardiology , Jg. 116 2021, Nr. 1, 62DOI (Open Access)
-
Detectable troponin below the 99th percentile predicts survival in patients with cardiovascular diseaseIn: European Heart Journal , Jg. 42 2021, Nr. Supplement_1, ehab724.1170DOI (Open Access)
-
Left ventricular global longitudinal strain reduction in patients with melanoma and extra-cardiac immune-related adverse events during immune checkpoint inhibitor therapy
ESC Congress 2020, 29 August – 1 September 2020, Amsterdam, digital,In: European Heart Journal , Jg. 41 2020, Nr. Supplement_2, S. 3261DOI (Open Access) -
Preclinical and clinical assessment of immune checkpoint inhibitor-associated left ventricular dysfunction
ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,In: European Heart Journal , Jg. 41 2020, Nr. Supplement_2, S. 3260DOI (Open Access) -
Tumor necrosis factor alpha blockade prevents immune checkpoint inhibitor therapy-related cardiotoxicity
ESC Congress 2020 – The Digital Experience 29 August – 1 September 2020,In: European Heart Journal , Jg. 41 2020, Nr. Supplement_2, S. 3250DOI (Open Access)